90% of ALS cases happen without family history, making it unpredictable. Research is key to understanding ALS and finding treatments, but we need participation. This #RareDiseaseDay, take action! 🔗 #TogetherForRare #ALSResearch #EveryActionMatters

ALS and other rare diseases have limited treatment options, but research can change that. Join us on #RareDiseaseDay to push ALS research forward by donating, participating in a study, or spreading awareness. Read More: #TogetherForRare #ALSResearch

Due to high demand, the validated pTDP-43 antibody—a critical tool for ALS research—is back through the Target ALS Reagents Core in collaboration with Dr. Len Petrucelli and DSHB. Request it here: and send a note to ellen.guss@targetals.org #ALS #TDP43

Target ALS is funding in vivo proof-of-concept studies to validate promising ALS therapeutics with Biospective. Researchers retain full IP rights. Apply by 3/24/25! Learn more: #ALSResearch #DrugDevelopment #Neuroscience #PreclinicalStudies #ALS

Every 90 minutes, ALS changes a life. We need action to push research forward. This #RareDiseaseDay, help us fight for progress by donating, joining a study, or raising awareness. Will you be 1 of the 90? 🔗 #TogetherForRare #ALSResearch #EveryoneLives

Join us for the Importance of ALS Research webinar with Chicanos Por La Causa on Feb 5, 2025, 5:30–7 PM MST. Learn about ALS research, its impact on the Hispanic community, & how you can make a difference. In-person (Phoenix) or virtual: #ALSResearch

Our friend and ALS warrior Geoff Greulich set out to raise $1M for ALS research—he’s already at $488K! After a tough ICU stay, his commitment is stronger than ever. Join us in supporting his mission to fund life-changing research. 🔗 #ALSSucks #Donate

Since its launch in March 2024, the Target ALS Data Engine has revolutionized ALS research, offering no-cost access to datasets. With 248+ applications worldwide, it connects across industries to accelerate breakthroughs. 🌍 Read: #TargetALS #ALSResearch

🔬 Meet Cooper Penner, MD-PhD candidate, caregiver to his late mother with ALS, and a C9orf72 carrier. Using the Target ALS Data Engine, he drives research, generates hypotheses, and explores treatments—breaking barriers with #RadicalCollaboration.

Postmortem tissue offers unmatched insights into #ALS, helping identify genetic markers and potential therapies. Target ALS's expanded Postmortem Core integrates multi-omic data and cutting-edge tech, driving global breakthroughs. Learn more #ALSResearch

Target ALS is driving progress in #ALSResearch, supporting 5 of 7 ASO therapies in development worldwide. These gene-based treatments target #ALS at its root, offering hope for life-changing solutions. Read more: #ASO #MND #Breakthroughs

Groundbreaking discoveries at the International ALS/MND Symposium bring new hope. From early TDP43 detection to personalized treatments, researchers are transforming #ALS diagnosis and therapy. Together, we’re building a future where #EveryoneLives.

ALS is devastating, but researchers like Dr. Kathryn Morelli, a Target ALS Springboard Fellow, are driving progress. Using our Stem Cell & Reagents Cores, she’s advancing RNA-targeted therapies for C9orf72. Together, we’re breaking barriers. Learn more:

The Target ALS #DataEngine breaks barriers in #ALSResearch, providing free or low-cost access to vital datasets. With user guides and tutorials, it empowers researchers—especially early-career scientists—to focus on breakthroughs, not roadblocks. 🔗

At Target ALS, our Research Cores democratize #ALSResearch, offering global access to cutting-edge tools at minimal to no cost. These resources empower researchers to accelerate breakthroughs and develop treatments faster than ever. Learn more:

On Dec 20, we hosted our first Community-Based Pop-Up Clinic in LA, welcoming 13 participants who provided samples & data to advance ALS research. Learn more: #DiversityInResearch #ALSResearch #EveryoneLives

We Surpassed Our Goal: Thank You! Thanks to your support, we exceeded our $100,000 goal and unlocked matching funds for ALS research. The fight isn’t over—donate today to keep driving progress:

At Target ALS, we disrupt the status quo by placing zero IP restrictions on funded research. This unique approach eliminates silos, accelerates collaboration, and speeds breakthroughs to those living with ALS. Support bold innovation:

Collaboration isn’t an ideal—it’s essential. Target ALS drives research breakthroughs, partnering with @ALSUnitedGNY for care, advocacy, & resources. Together, we’re transforming outcomes for #ALS families. Read more: #Collaboration #ALSResearch

As we reflect on 2024, we’re inspired by the courage of those living with ALS—the heart of all we do. From enrolling 180+ in our Global Study to funding breakthroughs, every step moves us closer to a future where #EveryoneLives. Happy Holidays! #GlobalImpact #ALSResearch #ALS